Both patients with Dravet syndrome and scn1lab mutant fish benefit from serotonergic compounds or KD, suggesting their metabolic actions may be mediated by a common pathway via PEPCK (Caraballo, 2011; Kumar et al., 2016). Here, PCK2 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.